Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial

Journal of Clinical Oncology

Volumn 32, Issue 8, 2014, Pages 791-797

  Wickberg, Åsa ^a   Holmberg, Lars ^b,d   Adami, Hans Olov ^c,e   Magnuson, Anders ^a   Villman, Kenneth ^a   Liljegren, Gor̈an ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; BREAST CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; ADJUVANT THERAPY; AGED; BREAST TUMOR; CANCER STAGING; CONTROLLED CLINICAL TRIAL; INCIDENCE; KAPLAN MEIER METHOD; METHODOLOGY; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE FRACTIONATION; RISK FACTOR; SWEDEN; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899626690     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.50.6600     Document Type: Article

References (16)

1. Early Breast Cancer Trialists' Collaborative Group, Darby S, McGale P, et al: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Metaanalysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707-1716, 2011
2. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
3. Darby SC, McGale P, Taylor CW, et al: Longterm mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557-565, 2005 (Pubitemid 41051933)
4. Harris EE: Cardiac mortality and morbidity after breast cancer treatment. Cancer Control 15:120-129, 2008
5. Darby SC, Ewertz M, McGale P, et al: Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987-998, 2013
6. Taylor CW, McGale P, Darby SC: Cardiac risks of breast-cancer radiotherapy: A contemporary view. Clin Oncol (R Coll Radiol) 18:236-246, 2006 (Pubitemid 43264360)
7. Schultz-Hector S, Trott KR: Radiation-induced cardiovascular diseases: Is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 67:10-18, 2007 (Pubitemid 44959506)
8. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002 (Pubitemid 35176242)
9. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002 (Pubitemid 35176241)
10. Liljegren G, Holmberg L, Bergh J, et al: 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 17:2326-2333, 1999 (Pubitemid 29368230)
11. Aspegren K, Holmberg L, Adami HO: Standardization of the surgical technique in breastconserving treatment of mammary cancer. Br J Surg 75:807-810, 1988
12. Uppsala-Örebro Breast Cancer Study Group: Sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Natl Cancer Inst 82:277-282, 1990
13. Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004 (Pubitemid 39166260)
14. Fyles AW, McCready DR, Manchul LA, et al: Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963-970, 2004
15. Fisher B, Bryant J, Dignam JJ, et al: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149, 2002 (Pubitemid 35191016)
16. Vichapat V, Garmo H, Holmqvist M, et al: Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study. J Clin Oncol 30:3478-3485, 2012